⌘K

Login Start Free

Home/Filings/4/0001104659-24-001373

4//SEC Filing

LUCI DAVID P 4

Accession 0001104659-24-001373

CIK 0001736243other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:24 PM ET

Size

8.1 KB

Accession

0001104659-24-001373

Insider Transaction Report

Form 4

Period: 2024-01-03

Acurx Pharmaceuticals, Inc.ACXP

DirectorPresident and CEO10% Owner

Transactions

Exercise/Conversion
Warrants for Common Stock
2024-01-03−19,737→ 0 total
Exercise: $3.55From: 2023-01-27Exp: 2024-01-27→ Common Stock (19,737 underlying)
Exercise/Conversion
Common Stock
2024-01-03$3.55/sh+19,737$70,066→ 1,048,197 total

Holdings

Common Stock
(indirect: By Spouse)
15,083
Common Stock
(indirect: By Children)
35,000

Documents

1 file

4
tm242052-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Acurx Pharmaceuticals, Inc.

CIK 0001736243

Entity typeother

Related Parties

1

filerCIK 0001271123

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 4:24 PM ET
Size: 8.1 KB

View on SEC.gov